Bugshan, A. and I. Farooq, Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis. F1000Res. 2020;9:229.
Chamoli A, et al. Overview of oral cavity squamous cell carcinoma: risk factors, mechanisms, and diagnostics. Oral Oncol. 2021;121:105451.
Howard A, Agrawal N, Gooi Z. Lip and oral cavity squamous cell carcinoma. Hematol Oncol Clin North Am. 2021;35(5):895–911.
Jiang M, Li B. STAT3 and its targeting inhibitors in oral squamous cell carcinoma. Cells. 2022;11(19):3131.
Article CAS PubMed PubMed Central Google Scholar
Pollaers K, et al. The economic burden of oral squamous cell carcinoma in Australia. J Oral Pathol Med. 2019;48(7):588–94.
Panarese I, et al. Oral and Oropharyngeal squamous cell carcinoma: prognostic and predictive parameters in the etiopathogenetic route. Expert Rev Anticancer Ther. 2019;19(2):105–19.
Article CAS PubMed Google Scholar
Chen SH, Li D, Xu C. Downregulation of Col1a1 induces differentiation in mouse spermatogonia. Asian J Androl. 2012;14(6):842–9.
Article CAS PubMed PubMed Central Google Scholar
Turecek C, et al. Collagen cross-linking influences osteoblastic differentiation. Calcif Tissue Int. 2008;82(5):392–400.
Article CAS PubMed Google Scholar
Li X, et al. COL1A1: A novel oncogenic gene and therapeutic target in malignancies. Pathol Res Pract. 2022;236: 154013.
Article CAS PubMed Google Scholar
Ma HP, et al. Collagen 1A1 (COL1A1) is a reliable biomarker and putative therapeutic target for hepatocellular carcinogenesis and metastasis. Cancers (Basel). 2019;11(6):786.
Article CAS PubMed Google Scholar
Liu J, et al. Collagen 1A1 (COL1A1) promotes metastasis of breast cancer and is a potential therapeutic target. Discov Med. 2018;25(139):211–23.
Wang Q, Yu J. MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1. Biochem Cell Biol. 2018;96(1):19–25.
Article CAS PubMed Google Scholar
Cui Z, et al. Construction of the miRNA-mRNA regulatory network and analysis of hub genes in oral squamous cell carcinoma. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2022;166(3):280–9.
Peng Y, et al. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis. J Cancer Res Clin Oncol. 2023;149(9):6097–113.
Article CAS PubMed Google Scholar
Garbo S, Zwergel C, Battistelli C. m6A RNA methylation and beyond - the epigenetic machinery and potential treatment options. Drug Discov Today. 2021;26(11):2559–74.
Article CAS PubMed Google Scholar
Sun Y, et al. N6-methyladenosine (m6A) methylation in kidney diseases: mechanisms and therapeutic potential. Biochim Biophys Acta Gene Regul Mech. 2023;1866(4):194967.
Article CAS PubMed Google Scholar
Chen L, et al. METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability. Nucleic Acids Res. 2022;50(20):11619–34.
Article CAS PubMed PubMed Central Google Scholar
Wen L, et al. The m6A methyltransferase METTL3 promotes LPS-induced microglia inflammation through TRAF6/NF-kappaB pathway. NeuroReport. 2022;33(6):243–51.
Article CAS PubMed Google Scholar
Liang H, Fang C, Zhang L. Methyltransferase-like 3 facilitates the stem cell properties of esophageal cancer by upregulating patched homolog 1 via N6-methyladenosine methylation. Am J Physiol Cell Physiol. 2023;325(3):C770–9.
Article CAS PubMed Google Scholar
Xu Y, et al. METTL3 promotes proliferation and migration of colorectal cancer cells by increasing SNHG1 stability. Mol Med Rep. 2023. https://doi.org/10.3892/mmr.2023.13104.
Article PubMed PubMed Central Google Scholar
Xu L, et al. m(6)A methyltransferase METTL3 promotes oral squamous cell carcinoma progression through enhancement of IGF2BP2-mediated SLC7A11 mRNA stability. Am J Cancer Res. 2021;11(11):5282–98.
CAS PubMed PubMed Central Google Scholar
Wu S, et al. Overexpression of methyltransferase-like 3 and 14 in oral squamous cell carcinoma. J Oral Pathol Med. 2022;51(2):134–45.
Article CAS PubMed Google Scholar
Keshani F, et al. Screening of oral squamous cell carcinoma by serum changes: a systematic review and meta-analysis. Dent Res J (Isfahan). 2021;18:88.
Li H, et al. The p38 signaling pathway mediates the TGF-beta1-induced increase in type I collagen deposition in human granulosa cells. FASEB J. 2020;34(11):15591–604.
Article CAS PubMed Google Scholar
Alpogan O. Association of osteogenesis imperfecta and glaucoma: case report. Ophthalmic Genet. 2023;44(5):475–9.
Article CAS PubMed Google Scholar
Pan TT, et al. A novel mutation in COL1A1 causing osteogenesis imperfecta/hearing loss. Braz J Otorhinolaryngol. 2023;89(5): 101312.
Article PubMed PubMed Central Google Scholar
Peris P, et al. Collagen type Ialpha1 gene polymorphism in idiopathic osteoporosis in men. Rheumatology (Oxford). 2000;39(11):1222–5.
Article CAS PubMed Google Scholar
Huang X, et al. LncRNA FBXL19-AS1 promotes proliferation and metastasis of cervical cancer through upregulating COL1A1 as a sponge of miR-193a-5p. J Biol Res (Thessalon). 2021;28(1):20.
Article CAS PubMed Google Scholar
Chen X, et al. CircRNA circ_0004370 promotes cell proliferation, migration, and invasion and inhibits cell apoptosis of esophageal cancer via miR-1301-3p/COL1A1 axis. Open Med (Wars). 2021;16(1):104–16.
He B, et al. MiR-133a-3p inhibits oral squamous cell carcinoma (Oscc) proliferation and invasion by suppressing COL1A1. J Cell Biochem. 2018;119(1):338–46.
Article CAS PubMed Google Scholar
Zhao Y, Yao R. Long non-coding RNA HOXA-AS3 promotes cell proliferation of oral squamous cell carcinoma through sponging microRNA miR-218-5p. Bioengineered. 2021;12(1):8724–37.
Article CAS PubMed PubMed Central Google Scholar
Han YK, et al. Promoter methylation of cancer stem cell surface markers as an epigenetic biomarker for prognosis of oral squamous cell carcinoma. Int J Mol Sci. 2022;23(23):14624.
Article CAS PubMed PubMed Central Google Scholar
Jiang X, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74.
Comments (0)